Much has been written about the uncertainty in U.S. patent law concerning laws of nature, natural phenomena, and abstract ideas. Goodwin's IP Litigation lawyer Robert Fredrickson explore the case of genetically modified plants and animals, and questions arising on where to draw the line between human invention and biological processes. Read the IPWatchdog by-line here.